Category: ProUroCare Medical Inc

No Image

Shareholder Update

Current status update Please bookmark this page and check back periodically for the latest updates on news, events, and milestone achievements of interest to shareholders and investors. Presentation at the August 22, 2013 Annual Meeting of Shareholders Stan Myrum reviews our progress and outlines future plans (Presentation). July, 2013 Letter…

chevron_right Read more

What is Elasticity Imaging?

Tissue Displacement Tissue displacement occurs anytime body tissue moves in response to pressure. As areas of abnormal tissue form within an organ, the tissue often becomes more dense and less elastic. When pressure is applied to the organ, abnormal tissue generally exhibits less displacement than normal tissue. This difference can…

chevron_right Read more

Prostate Disease

Prostate cancer is the most common form of cancer and the second leading cause of cancer death in men over the age of 50. The National Cancer Institute estimates that approximately 241,000 men were diagnosed with prostate cancer and over 33,000 died from the disease in 2011. Screening. Currently, there…

chevron_right Read more

The ProUroScan™ Prostate Imaging System

ProUroScan is an advanced medical imaging system that uses an array of sensors mounted on a rectal probe, a central processing unit and software and image construction algorithms to provide a real time color image of abnormalities in the prostate. The system provides an image or record of the pressures…

chevron_right Read more
No Image

Letter to Creditors and Shareholders December 17, 2014

Letter to Creditors and Shareholders December 17, 2014 Innovative Elasticity Imaging Technology Prostate cancer is the most common form of cancer and the second leading cause of cancer death in men. The current standard of care is to screen for the presence of prostate cancer beginning at age 50, normally…

chevron_right Read more